Iron Saturation (TSAT): How Much of Your Transferrin Is Carrying Iron

What iron saturation (TSAT) actually measures

Iron saturation, also called transferrin saturation (TSAT), is the percentage of transferrin — the main iron-transport protein — currently carrying iron at any given moment. It is calculated from two values in the same blood draw: serum iron divided by total iron-binding capacity (TIBC), multiplied by 100. Physiologically, it is a snapshot of supply and demand — higher values indicate more iron is available relative to carrying capacity; lower values suggest iron is scarce or functionally restricted.

Why TSAT shows what ferritin alone cannot

Think of transferrin as a fleet of rideshares for iron. Iron cannot travel freely in the bloodstream; it needs a seat. Transferrin provides the seats. TSAT tells you how many of those seats are occupied — not how much iron is sitting in storage, which is what ferritin reflects.

Serum iron alone fluctuates hour to hour with meals, supplements, and time of day. TIBC reflects how much transport-protein capacity exists. The ratio of the two captures the iron-loading state of the entire transport system, not just a raw iron count. That distinction matters because the body regulates iron delivery through a hormone called hepcidin. When inflammation is present — signalled by cytokines such as IL-6 — hepcidin rises, instructing intestinal cells and storage sites to retain iron. Less iron enters circulation, serum iron falls, and TSAT drops even when total body iron stores are adequate or elevated. Ferritin, meanwhile, rises with the same inflammatory signal, creating a misleading picture of iron sufficiency. TSAT cuts through that: a low TSAT alongside a high ferritin during illness points to functional iron restriction — iron is present but not available to the transport system.

How iron saturation is calculated as a percentage

TSAT is derived from two values in the same blood draw: serum iron (the amount of iron circulating in plasma) and TIBC (total iron-binding capacity, which reflects transferrin protein availability). Dividing iron by TIBC and multiplying by 100 expresses the result as a percentage of transport capacity currently occupied.

Iron Saturation (TSAT): (Serum Iron [µg/dL] ÷ Total Iron-Binding Capacity [µg/dL]) × 100

Result expressed as a percentage (%). Example: Serum iron = 75 µg/dL, TIBC = 350 µg/dL → TSAT = (75 ÷ 350) × 100 = 21.4%.

Some labs report transferrin directly (g/dL) rather than TIBC; an estimated TIBC can be derived from transferrin: TIBC ≈ Transferrin (g/dL) × 70.9 µg/dL. Lab-reported TSAT is calculated automatically when all three values are in the same panel.

Serum iron varies significantly with recent food intake, iron supplements, and time of day — values are highest in the morning and fall by up to 30–50% in the afternoon. Draw in the morning after an overnight fast (8–12 hours) and hold any iron supplements for at least 24 hours before the draw. Test 4 weeks or more after any IV iron infusion. Do not draw during acute illness — a hepcidin spike will suppress serum iron and produce a falsely low TSAT.

A worked example: a 32-year-old woman with serum iron of 48 µg/dL and TIBC of 420 µg/dL has TSAT = (48 ÷ 420) × 100 = 11.4% — well below the 20% lower threshold, consistent with iron deficiency. Her ferritin is also 8 ng/mL (depleted stores). Paired low TSAT + low ferritin is the classic iron-deficiency pattern. Contrast: the same TSAT of 11% alongside ferritin of 180 ng/mL and elevated hs-CRP — low TSAT despite high ferritin — points instead to functional iron restriction from inflammation (hepcidin sequestration), where iron is present but not available to the transport system.

Reading your TSAT result across the ranges

Reference intervals come from large populations, not from any individual. Many labs report TSAT as typical in the range of 20–45%, but ranges vary by method and laboratory. Context — sex, life stage, and inflammatory status — shapes what a given number means.

• Below 20%: associated with iron deficiency or functional iron restriction from inflammation; warrants evaluation alongside ferritin and hs-CRP to distinguish the two.
• 20–30%: low-normal — may warrant iron-status evaluation in context, particularly if symptoms such as fatigue, hair shedding, or poor exercise recovery are present.
• 30–45%: typical healthy range for most adults.
• Above 45% with elevated ferritin: associated with iron overload — evaluate for hemochromatosis and assess liver health per clinical guidelines.
• Above 45% in isolation: may reflect reduced transferrin from liver disease or a timing artifact following recent IV iron — a repeat fasting morning draw helps distinguish true overload from a transient or structural finding.

Reliable interpretation requires consistent draw conditions. Serum iron follows a diurnal pattern — values are highest in the morning and can fall substantially by afternoon. Iron consumed in food or supplements raises serum iron acutely and will inflate TSAT for several hours. A same-morning, fasting, pre-supplement draw is the minimum requirement for a meaningful baseline or trend comparison.

Men and postmenopausal women tend to have steadier iron balance; people who menstruate are more likely to run low. Pregnancy naturally increases transferrin production, which can pull TSAT down even as total iron needs rise. Chronic inflammation lowers both transferrin and serum iron, shifting TSAT in ways that do not reflect true iron stores. TSAT is best interpreted alongside ferritin, hemoglobin, and a marker of inflammation.

What pushes TSAT high or low

Hepcidin and inflammatory iron withholding

The primary regulator of TSAT is hepcidin. Inflammatory signals — particularly IL-6 — drive hepcidin production, which instructs ferroportin channels in intestinal cells and macrophages to retain iron. The result is reduced iron entry into circulation, a falling serum iron, and a lower TSAT. This mechanism explains why TSAT can be low during active infection or chronic inflammatory conditions even when total body iron is normal or elevated. Oral contraceptives and pregnancy increase transferrin production, which dilutes TSAT. Liver disease reduces transferrin synthesis, making TSAT appear higher than the underlying iron status warrants. Chronic kidney disease frequently creates functional iron deficiency — TSAT sits low despite adequate stores, particularly when erythropoiesis-stimulating agents increase marrow demand.

Dietary iron absorption: heme vs non-heme, vitamin C, and inhibitors

Food moves TSAT by changing both the amount of iron absorbed and the signals governing absorption. Heme iron from animal sources is absorbed efficiently; non-heme iron from plants is more variable. Vitamin C enhances non-heme iron uptake by maintaining it in a soluble form. Co-ingestion of calcium or polyphenols (found in tea, coffee, and many plant foods) is associated with reduced non-heme iron absorption in research studies. Phytates in whole grains and legumes have a similar inhibitory effect; soaking, sprouting, or fermenting these foods reduces phytate content and improves bioavailability. Alcohol can increase iron absorption and, with chronic use, lower transferrin production. Chronic proton pump inhibitor use reduces gastric acid, which can limit non-heme iron absorption. After bariatric surgery, reduced acid secretion and altered intestinal anatomy frequently push TSAT down.

Exercise-related hepcidin transience and footstrike hemolysis

A hard training session can transiently raise hepcidin for several hours, shunting iron into storage and lowering serum iron during that window. Footstrike and muscle stress can also increase iron turnover through mild hemolysis, particularly in high-mileage runners. These are short-term effects; long-term, consistent training reduces chronic inflammation and supports more predictable hepcidin rhythms and steadier iron availability.

Medications, conditions, and genetics

Testosterone therapy increases red cell production and can alter iron dynamics. Adequate copper is necessary for iron mobilization; copper deficiency can produce a low TSAT despite normal iron stores. Variants in HFE associated with hereditary hemochromatosis increase iron absorption over decades; persistent TSAT above approximately 45% with a climbing ferritin prompts many clinicians to evaluate for this pattern based on guidelines. Frequent blood donation and heavy menstrual bleeding drive the opposite pattern: a low TSAT that improves when iron losses slow.

The iron-panel markers that contextualize TSAT

• Ferritin — reflects iron stores but also rises with inflammation; TSAT provides the circulating-iron counterpart. A low TSAT alongside elevated ferritin during illness indicates functional iron restriction, not true iron excess.
• Serum iron (iron, total) — the numerator of TSAT; understanding absolute serum iron alongside TSAT distinguishes whether a low TSAT reflects low iron supply or high transport capacity from iron deficiency.
• Total iron-binding capacity (TIBC) — the denominator of TSAT; it rises in iron deficiency (more transferrin available) and falls in inflammation or liver disease (less transferrin produced). Pairing TIBC with TSAT reveals the transport-protein context behind the ratio.
• Hemoglobin — drops when TSAT-related iron restriction begins to limit erythropoiesis; pairing TSAT with hemoglobin shows whether iron supply has started to affect red-cell production.
• hs-CRP — distinguishes true iron deficiency (low TSAT + low hs-CRP) from inflammatory iron withholding (low TSAT + high hs-CRP); essential for correctly interpreting TSAT during any active illness or inflammatory state.

Timing the TSAT retest with a fasted morning draw

Serum iron has significant diurnal variability — a same-morning, fasting, pre-supplement, pre-exercise draw is the minimum requirement for a meaningful trend comparison. Consistency in draw conditions matters as much as the interval between tests.

On oral iron repletion, TSAT typically responds within 4–8 weeks; ferritin takes longer — 8–12 weeks — to replete. A retest at 8–12 weeks captures both. On phlebotomy for hemochromatosis, TSAT and ferritin should be checked every 2–4 weeks during the depletion phase, then every 3–6 months for maintenance, as directed by a clinician. For healthy adults monitoring iron status, testing annually or when symptomatic (fatigue, restless legs, hair shedding) is a reasonable cadence.

After intense exercise, avoid drawing for at least 24 hours — the post-exercise hepcidin spike produces a transiently suppressed serum iron and an artificially low TSAT that does not reflect baseline status. Use the same laboratory, the same morning draw time, a consistent overnight fast, and the same iron-supplement hold protocol (at least 24 hours) across all retests to ensure that changes in the number reflect changes in iron status rather than changes in conditions.

When a sustained TSAT result warrants follow-up

A single out-of-range TSAT is a prompt to investigate conditions, not a diagnosis. Sustained patterns — confirmed on repeat fasting morning draws — are what warrant clinical follow-up.

On the low end: TSAT persistently below 20%, particularly alongside low ferritin or symptoms such as fatigue, reduced endurance, hair shedding, or restless legs, signals a supply problem affecting oxygen delivery and tissue metabolism. Even before hemoglobin falls, low TSAT correlates with reduced aerobic capacity and slower recovery, likely through decreased mitochondrial function and altered thyroid hormone activation.

On the high end: TSAT persistently above 45% with a climbing ferritin raises the question of iron overload. Sustained iron excess is associated with liver cirrhosis, cardiomyopathy, and metabolic dysfunction over time. Evaluation for hereditary hemochromatosis and assessment of liver health are appropriate next steps per clinical guidelines.

TSAT is not reliably interpretable in the following circumstances and should not be acted on at face value:

• Acute illness — hepcidin rises and serum iron drops artifactually regardless of true iron status.
• Within hours of an iron-rich meal or oral iron supplement — serum iron rises acutely and TSAT will be falsely elevated.
• Within 2–4 weeks of IV iron infusion — ferritin and TSAT both remain elevated from the infusion and do not reflect underlying status.
• Severe liver disease — transferrin production is low, so TSAT appears high due to a reduced denominator, not true iron overload.

Tracking TSAT alongside ferritin, hemoglobin, and hs-CRP over time moves iron assessment from a single data point to a pattern — one that connects how you feel and perform to what is actually happening in your transport system. That is the kind of clarity that supports informed decisions made with a clinician, grounded in evidence rather than guesswork. Superpower is built around that approach: comprehensive biomarker panels that place TSAT in the context of over 100 markers, so iron status is never read in isolation.